RGRosa Chiara Goisis

Rosa Chiara Goisis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rosa Chiara Goisis has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Altered Cl − homeostasis hinders forebrain GABAergic interneuron migration in a mouse model of intellectual disability

    by Andrea Maset, Luisa Galla, Simona Francia, Olga Cozzolino, Paola Capasso, Rosa Chiara Goisis, Gabriele Losi, Angelo Lombardo, Gian Michele Ratto, Claudia Lodovichi

    Impairments of inhibitory circuits are at the basis of most, if not all, cognitive deficits. The impact of OPHN1, a gene associate with intellectual disability (ID), on inhibitory neurons remains elusive. We addressed this issue by analyzing the postnatal migration of inhibitory interneurons derived from the subventricular zone in a validated mouse model of ID (OPHN1−/y mice). We found that the speed and directionality of migrating neuroblasts were deeply perturbed in OPHN1−/y mice. The significant reduction in speed was due to altered chloride (Cl−) homeostasis, while the overactivation of the OPHN1 downstream signaling pathway, RhoA kinase (ROCK), caused abnormalities in the directionality of the neuroblast progression in mutants. Blocking the cation–Cl− cotransporter KCC2 almost completely rescued the migration speed while proper directionality was restored upon ROCK inhibition. Our data unveil a strong impact of OPHN1 on GABAergic inhibitory interneurons and identify putative targets for successful therapeutic approaches. Significance Intellectual disability associated with Oligophrenin 1 (OPHN1) mutation is a neurodevelopmental disorder characterized by a wide range of cognitive and social dysfunction. Here, we dissected the impact of OPHN1 mutation on the postnatal migration of inhibitory interneurons, a process that is thought to play a key role in postnatal developmental plasticity. We found that loss of function of OPHN1 led to an early maturation of the morphofunctional properties of the neuronal precursors that impaired their migration and resulted in a dramatically lower number of cells reaching their target area. We identified pharmacological treatments able to rescue the abnormal development of neuronal precursors and their migration.


  • L‐alpha‐aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson’s disease in male rats

    by Eoin O’neill, Rosa Chiara Goisis, Ruth Haverty, Andrew Harkin

    Neuroinflammation is a contributory factor underlying the progressive nature of dopaminergic neuronal loss within the substantia nigra (SN) of Parkinson's disease (PD) patients, albeit the role of astrocytes in this process has been relatively unexplored to date. Here, we aimed to investigate the impact of midbrain astrocytic dysfunction in the pathophysiology of intra‐nigral lipopolysaccharide (LPS)‐induced experimental Parkinsonism in male Wistar rats via simultaneous co‐injection of the astrocytic toxin L‐alpha‐aminoadipic acid (L‐AAA). Simultaneous intra‐nigral injection of L‐AAA attenuated the LPS‐induced loss of tyrosine hydroxylase‐positive (TH+) dopamine neurons in the SNpc and suppressed the affiliated degeneration of TH+ dopaminergic nerve terminals in the striatum. L‐AAA also repressed LPS‐induced nigrostriatal dopamine depletion and provided partial protection against ensuing motor dysfunction. L‐AAA abrogated intra‐nigral LPS‐induced glial fibrillary acidic protein‐positive (GFAP+) reactive astrogliosis and attenuated the LPS‐mediated increases in nigral S100β expression levels in a time‐dependent manner, findings which were associated with reduced ionized calcium binding adaptor molecule 1‐positive (Iba1+) microgliosis, thus indicating a role for reactive astrocytes in sustaining microglial activation at the interface of dopaminergic neuronal loss in response to an immune stimulus. These results indicate that midbrain astrocytic dysfunction restricts the development of dopaminergic neuropathology and motor impairments in rats, highlighting reactive astrocytes as key contributors in inflammatory associated degeneration of the nigrostriatal tract.